1-6 of 6
Stella Flampouri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study

Shivam M. Kharod, MD, R. Charles Nichols, MD, Randal H. Henderson, MD, MBA, Christopher G. Morris, MS, Dat C. Pham, MD ...
Journal: International Journal of Particle Therapy
Int J Part Ther (2020) 7 (2): 1–10.
https://doi.org/10.14338/IJPT-20-00013.1
Published: 06 November 2020
View article titled, Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study
Open the PDF for Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study in another window
Journal Articles

Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma

Bradford S. Hoppe, MD, MPH, Raymond B. Mailhot Vega, MD, MPH, Nancy P. Mendenhall, MD, Eric S. Sandler, MD, William B. Slayton, MD ...
Journal: International Journal of Particle Therapy
Int J Part Ther (2020) 6 (4): 11–16.
https://doi.org/10.14338/IJPT-19-00077.1
Published: 27 April 2020
View article titled, Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma
Open the PDF for Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma in another window
Journal Articles

Cardiac MRI for Detecting Early Cardiac Toxicity after Proton Therapy for Hodgkin Lymphoma

James E. Bates, MD, Christopher Klassen, MD, PhD, Savas Ozdemir, MD, Stella Flampouri, PhD, Robert Percy, MD ...
Journal: International Journal of Particle Therapy
Int J Part Ther (2019) 5 (4): 41–44.
https://doi.org/10.14338/IJPT-19-00052.1
Published: 07 May 2019
View article titled, Cardiac MRI for Detecting Early Cardiac Toxicity after Proton Therapy for Hodgkin Lymphoma
Open the PDF for Cardiac MRI for Detecting Early Cardiac Toxicity after Proton Therapy for Hodgkin Lymphoma in another window
Journal Articles

Evaluating Cardiac Biomarkers after Chemotherapy and Proton Therapy for Mediastinal Hodgkin Lymphoma

Lidia Guzhva, Nancy P. Mendenhall, MD, Christopher G. Morris, MS, Stella Flampouri, PhD, Bradford S. Hoppe, MD, MPH
Journal: International Journal of Particle Therapy
Int J Part Ther (2017) 4 (2): 35–38.
https://doi.org/10.14338/IJPT-D-17-00022
Published: 28 December 2017
View article titled, Evaluating Cardiac Biomarkers after Chemotherapy and Proton Therapy for Mediastinal Hodgkin Lymphoma
Open the PDF for Evaluating Cardiac Biomarkers after Chemotherapy and Proton Therapy for Mediastinal Hodgkin Lymphoma in another window
Journal Articles

Comparing Breath Hold and Free Breathing during Intensity-Modulated Radiation Therapy and Proton Therapy in Patients with Mediastinal Hodgkin Lymphoma

Bradford S. Hoppe, MD, MPH, Nancy P. Mendenhall, MD, Debbie Louis, CMD, Zuofeng Li, DSc, Stella Flampouri, PhD
Journal: International Journal of Particle Therapy
Int J Part Ther (2017) 3 (4): 492–496.
https://doi.org/10.14338/IJPT-17-00012
Published: 11 July 2017
View article titled, Comparing Breath Hold and Free Breathing during Intensity-Modulated Radiation Therapy and Proton Therapy in Patients with Mediastinal Hodgkin Lymphoma
Open the PDF for Comparing Breath Hold and Free Breathing during Intensity-Modulated Radiation Therapy and Proton Therapy in Patients with Mediastinal Hodgkin Lymphoma in another window
Journal Articles

Advancing the Therapeutic Index in Stage III/IV Pediatric Hodgkin Lymphoma with Proton Therapy

Adam L. Holtzman, MD, Bradford S. Hoppe, MD, MPH, Zuofeng Li, DSc, Zhong Su, PhD, William B. Slayton, MD ...
Journal: International Journal of Particle Therapy
Int J Part Ther (2014) 1 (2): 343–356.
https://doi.org/10.14338/IJPT.14.00001.1
Published: 08 September 2014
View article titled, Advancing the Therapeutic Index in Stage III/IV Pediatric Hodgkin Lymphoma with Proton Therapy
Open the PDF for Advancing the Therapeutic Index in Stage III/IV Pediatric Hodgkin Lymphoma with Proton Therapy in another window